HEADER TRANSFERASE 14-AUG-05 2AOU TITLE HISTAMINE METHYLTRANSFERASE COMPLEXED WITH THE ANTIMALARIAL TITLE 2 DRUG AMODIAQUINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTAMINE N-METHYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HMT; COMPND 5 EC: 2.1.1.8; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HISTAMINE N-METHYLTRANSFERASE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HNMT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-3; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: HNMT; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: DH5A; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PGEX-4T-3 KEYWDS CLASSIC METHYLTRANSFERASE FOLD, PROTEIN-DRUG COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.R.HORTON,K.SAWADA,M.NISHIBORI,X.CHENG REVDAT 3 24-FEB-09 2AOU 1 VERSN REVDAT 2 18-OCT-05 2AOU 1 JRNL REVDAT 1 13-SEP-05 2AOU 0 JRNL AUTH J.R.HORTON,K.SAWADA,M.NISHIBORI,X.CHENG JRNL TITL STRUCTURAL BASIS FOR INHIBITION OF HISTAMINE JRNL TITL 2 N-METHYLTRANSFERASE BY DIVERSE DRUGS JRNL REF J.MOL.BIOL. V. 353 334 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16168438 JRNL DOI 10.1016/J.JMB.2005.08.040 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.R.HORTON,K.SAWADA,M.NISHIBORI,X.ZHANG,X.CHENG REMARK 1 TITL POLYMORPHIC FORMS OF HUMAN HISTAMINE REMARK 1 TITL 2 METHYLTRANSFERASE: STRUCTURAL, THERMAL, AND REMARK 1 TITL 3 KINETIC COMPARISONS REMARK 1 REF STRUCTURE V. 9 837 2001 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 26928 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2696 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE : 0.3000 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 159 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4515 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 306 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.33000 REMARK 3 B22 (A**2) : -1.33000 REMARK 3 B33 (A**2) : 2.67000 REMARK 3 B12 (A**2) : 1.65000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 30.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.26 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.40 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.90 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2AOU COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-AUG-05. REMARK 100 THE RCSB ID CODE IS RCSB034143. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-00 REMARK 200 TEMPERATURE (KELVIN) : 173 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X26C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE-CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26928 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: GLRF REMARK 200 STARTING MODEL: PDB ENTRY 1JQD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, MES, ETHYLENEGLYCOL, PH REMARK 280 6.2, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 6 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z REMARK 290 6555 X-Y,X,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 6 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 9 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 11 CG OD1 OD2 REMARK 470 VAL A 16 CG1 CG2 REMARK 470 ARG A 20 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 21 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 104 CG CD CE NZ REMARK 470 SER A 106 OG REMARK 470 LYS A 112 CG CD CE NZ REMARK 470 LYS A 131 CG CD CE NZ REMARK 470 LYS A 149 CG CD CE NZ REMARK 470 SER A 188 OG REMARK 470 GLN A 192 CG CD OE1 NE2 REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 ASP A 232 CG OD1 OD2 REMARK 470 GLU A 235 CG CD OE1 OE2 REMARK 470 THR A 253 OG1 CG2 REMARK 470 ASP A 257 CG OD1 OD2 REMARK 470 LYS A 264 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 GLU A 276 CG CD OE1 OE2 REMARK 470 SER B 4 OG REMARK 470 ARG B 6 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 9 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 14 CG CD CE NZ REMARK 470 ARG B 20 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 97 CG CD CE NZ REMARK 470 ASN B 107 CG OD1 ND2 REMARK 470 GLU B 129 CG CD OE1 OE2 REMARK 470 LYS B 130 CG CD CE NZ REMARK 470 LYS B 131 CG CD CE NZ REMARK 470 GLU B 132 CG CD OE1 OE2 REMARK 470 GLN B 192 CG CD OE1 NE2 REMARK 470 LYS B 214 CG CD CE NZ REMARK 470 GLU B 235 CG CD OE1 OE2 REMARK 470 ALA B 252 CB REMARK 470 ALA B 254 CB REMARK 470 LYS B 264 CG CD CE NZ REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 LYS B 275 CG CD CE NZ REMARK 470 GLU B 276 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 108 O - C - N ANGL. DEV. = 11.4 DEGREES REMARK 500 GLU B 109 CA - C - N ANGL. DEV. = -17.5 DEGREES REMARK 500 GLU B 109 O - C - N ANGL. DEV. = -21.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 10 -74.84 -63.15 REMARK 500 ASP A 11 82.43 -69.68 REMARK 500 HIS A 12 -34.78 -39.66 REMARK 500 MET A 144 -0.94 -145.78 REMARK 500 ARG A 189 -17.68 -46.68 REMARK 500 ASP A 232 -55.65 -20.07 REMARK 500 LYS A 278 153.20 -43.23 REMARK 500 SER B 10 -16.42 -49.74 REMARK 500 ASP B 232 -35.72 -24.70 REMARK 500 ASN B 234 113.55 -33.57 REMARK 500 THR B 253 -1.50 -156.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU B 109 30.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN ANY ONE OF THE THREE ETHYL GROUPS ON LIGAND, CQA 400 REMARK 600 COULD BE THE ALTERNATIVE CONFORMATION OF THE OTHER TWO (BY THE REMARK 600 ROTATION OF APPROXIMATELY 120 OR 240 DRGREES). REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 CQA B 400 REMARK 610 CQA B 401 REMARK 610 CQA A 403 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CQA B 400 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CQA A 402 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CQA B 401 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CQA A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1JQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE REMARK 900 METHYLTRANSFERASE (THR105 POLYMORPHIC VARIANT) COMPLEXED REMARK 900 WITH ADOHCY AND HISTAMINE REMARK 900 RELATED ID: 1JQE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF HUMAN HISTAMINE REMARK 900 METHYLTRANSFERASE (ILE105 POLYMORPHIC VARIANT) COMPLEXED REMARK 900 WITH ADOHCY AND ANTIMALARIAL DRUG QUINACRINE REMARK 900 RELATED ID: 2AOT RELATED DB: PDB REMARK 900 RELATED ID: 2AOV RELATED DB: PDB REMARK 900 RELATED ID: 2AOW RELATED DB: PDB REMARK 900 RELATED ID: 2AOX RELATED DB: PDB DBREF 2AOU A 1 292 UNP P50135 HNMT_HUMAN 1 292 DBREF 2AOU B 1 292 UNP P50135 HNMT_HUMAN 1 292 SEQADV 2AOU CYS A 82 UNP P50135 CYS 82 MODIFIED RESIDUE SEQADV 2AOU CSO A 217 UNP P50135 CYS 217 MODIFIED RESIDUE SEQADV 2AOU DCY A 248 UNP P50135 CYS 248 MODIFIED RESIDUE SEQADV 2AOU CSO B 82 UNP P50135 CYS 82 MODIFIED RESIDUE SEQADV 2AOU CYS B 217 UNP P50135 CYS 217 MODIFIED RESIDUE SEQADV 2AOU CYS B 248 UNP P50135 CYS 248 MODIFIED RESIDUE SEQRES 1 A 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 A 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 A 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 A 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 A 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 A 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 A 292 PRO GLY VAL CYS ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 A 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 A 292 THR SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 A 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 A 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 A 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 A 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 A 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 A 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 A 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 A 292 ASP ASN LEU GLY LEU LYS TYR GLU CSO TYR ASP LEU LEU SEQRES 18 A 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 A 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 A 292 DCY ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 A 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 A 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 A 292 PHE ILE VAL ILE GLU ALA SEQRES 1 B 292 MET ALA SER SER MET ARG SER LEU PHE SER ASP HIS GLY SEQRES 2 B 292 LYS TYR VAL GLU SER PHE ARG ARG PHE LEU ASN HIS SER SEQRES 3 B 292 THR GLU HIS GLN CYS MET GLN GLU PHE MET ASP LYS LYS SEQRES 4 B 292 LEU PRO GLY ILE ILE GLY ARG ILE GLY ASP THR LYS SER SEQRES 5 B 292 GLU ILE LYS ILE LEU SER ILE GLY GLY GLY ALA GLY GLU SEQRES 6 B 292 ILE ASP LEU GLN ILE LEU SER LYS VAL GLN ALA GLN TYR SEQRES 7 B 292 PRO GLY VAL CSO ILE ASN ASN GLU VAL VAL GLU PRO SER SEQRES 8 B 292 ALA GLU GLN ILE ALA LYS TYR LYS GLU LEU VAL ALA LYS SEQRES 9 B 292 THR SER ASN LEU GLU ASN VAL LYS PHE ALA TRP HIS LYS SEQRES 10 B 292 GLU THR SER SER GLU TYR GLN SER ARG MET LEU GLU LYS SEQRES 11 B 292 LYS GLU LEU GLN LYS TRP ASP PHE ILE HIS MET ILE GLN SEQRES 12 B 292 MET LEU TYR TYR VAL LYS ASP ILE PRO ALA THR LEU LYS SEQRES 13 B 292 PHE PHE HIS SER LEU LEU GLY THR ASN ALA LYS MET LEU SEQRES 14 B 292 ILE ILE VAL VAL SER GLY SER SER GLY TRP ASP LYS LEU SEQRES 15 B 292 TRP LYS LYS TYR GLY SER ARG PHE PRO GLN ASP ASP LEU SEQRES 16 B 292 CYS GLN TYR ILE THR SER ASP ASP LEU THR GLN MET LEU SEQRES 17 B 292 ASP ASN LEU GLY LEU LYS TYR GLU CYS TYR ASP LEU LEU SEQRES 18 B 292 SER THR MET ASP ILE SER ASP CYS PHE ILE ASP GLY ASN SEQRES 19 B 292 GLU ASN GLY ASP LEU LEU TRP ASP PHE LEU THR GLU THR SEQRES 20 B 292 CYS ASN PHE ASN ALA THR ALA PRO PRO ASP LEU ARG ALA SEQRES 21 B 292 GLU LEU GLY LYS ASP LEU GLN GLU PRO GLU PHE SER ALA SEQRES 22 B 292 LYS LYS GLU GLY LYS VAL LEU PHE ASN ASN THR LEU SER SEQRES 23 B 292 PHE ILE VAL ILE GLU ALA MODRES 2AOU CSO A 217 CYS S-HYDROXYCYSTEINE MODRES 2AOU CSO B 82 CYS S-HYDROXYCYSTEINE HET CSO A 217 7 HET DCY A 248 6 HET CSO B 82 13 HET CQA B 400 27 HET CQA A 402 25 HET CQA B 401 21 HET CQA A 403 23 HETNAM CSO S-HYDROXYCYSTEINE HETNAM DCY D-CYSTEINE HETNAM CQA 4-[(7-CHLOROQUINOLIN-4-YL)AMINO]-2-[(DIETHYLAMINO) HETNAM 2 CQA METHYL]PHENOL HETSYN CQA AMODIAQUINE, FLAVOQUINE FORMUL 1 CSO 2(C3 H7 N O3 S) FORMUL 1 DCY C3 H7 N O2 S FORMUL 3 CQA 4(C20 H22 CL N3 O) FORMUL 7 HOH *306(H2 O) HELIX 1 1 ASP A 11 HIS A 25 1 15 HELIX 2 2 THR A 27 LYS A 39 1 13 HELIX 3 3 LYS A 39 ILE A 44 1 6 HELIX 4 4 GLY A 64 TYR A 78 1 15 HELIX 5 5 SER A 91 THR A 105 1 15 HELIX 6 6 THR A 119 LYS A 130 1 12 HELIX 7 7 MET A 144 VAL A 148 5 5 HELIX 8 8 ASP A 150 SER A 160 1 11 HELIX 9 9 SER A 177 GLY A 187 1 11 HELIX 10 10 THR A 200 GLY A 212 1 13 HELIX 11 11 SER A 227 ILE A 231 5 5 HELIX 12 12 ASN A 234 GLU A 246 1 13 HELIX 13 13 ASN A 249 ALA A 254 1 6 HELIX 14 14 PRO A 255 LEU A 266 1 12 HELIX 15 15 SER B 7 SER B 10 5 4 HELIX 16 16 ASP B 11 ASN B 24 1 14 HELIX 17 17 THR B 27 LYS B 39 1 13 HELIX 18 18 LYS B 39 ILE B 44 1 6 HELIX 19 19 GLY B 64 TYR B 78 1 15 HELIX 20 20 SER B 91 LYS B 104 1 14 HELIX 21 21 THR B 119 LEU B 128 1 10 HELIX 22 22 MET B 144 VAL B 148 5 5 HELIX 23 23 ASP B 150 LEU B 161 1 12 HELIX 24 24 SER B 177 GLY B 187 1 11 HELIX 25 25 SER B 188 PHE B 190 5 3 HELIX 26 26 THR B 200 GLY B 212 1 13 HELIX 27 27 SER B 227 ILE B 231 5 5 HELIX 28 28 ASN B 234 GLU B 246 1 13 HELIX 29 29 ASN B 249 THR B 253 5 5 HELIX 30 30 PRO B 255 LEU B 266 1 12 SHEET 1 A 7 VAL A 111 HIS A 116 0 SHEET 2 A 7 CYS A 82 VAL A 88 1 N VAL A 87 O ALA A 114 SHEET 3 A 7 GLU A 53 ILE A 59 1 N SER A 58 O GLU A 86 SHEET 4 A 7 TRP A 136 ILE A 142 1 O PHE A 138 N LEU A 57 SHEET 5 A 7 LEU A 162 VAL A 173 1 O GLY A 163 N TRP A 136 SHEET 6 A 7 LEU A 285 GLU A 291 -1 O ILE A 288 N ILE A 170 SHEET 7 A 7 TYR A 215 LEU A 220 -1 N TYR A 218 O PHE A 287 SHEET 1 B 3 THR A 223 ASP A 225 0 SHEET 2 B 3 LYS A 278 ASN A 282 -1 O PHE A 281 N MET A 224 SHEET 3 B 3 SER A 272 LYS A 275 -1 N ALA A 273 O LEU A 280 SHEET 1 C 7 VAL B 111 HIS B 116 0 SHEET 2 C 7 CSO B 82 VAL B 88 1 N ILE B 83 O LYS B 112 SHEET 3 C 7 GLU B 53 ILE B 59 1 N SER B 58 O GLU B 86 SHEET 4 C 7 TRP B 136 ILE B 142 1 O PHE B 138 N LEU B 57 SHEET 5 C 7 LEU B 162 VAL B 173 1 O GLY B 163 N TRP B 136 SHEET 6 C 7 LEU B 285 GLU B 291 -1 O ILE B 288 N ILE B 170 SHEET 7 C 7 TYR B 215 LEU B 220 -1 N TYR B 218 O PHE B 287 SHEET 1 D 3 THR B 223 ASP B 225 0 SHEET 2 D 3 LYS B 278 ASN B 282 -1 O PHE B 281 N MET B 224 SHEET 3 D 3 SER B 272 LYS B 275 -1 N ALA B 273 O LEU B 280 LINK C GLU A 216 N CSO A 217 1555 1555 1.33 LINK C CSO A 217 N TYR A 218 1555 1555 1.34 LINK C THR A 247 N DCY A 248 1555 1555 1.33 LINK C DCY A 248 N ASN A 249 1555 1555 1.33 LINK C VAL B 81 N ACSO B 82 1555 1555 1.33 LINK C VAL B 81 N BCSO B 82 1555 1555 1.33 LINK C ACSO B 82 N ILE B 83 1555 1555 1.33 LINK C BCSO B 82 N ILE B 83 1555 1555 1.33 SITE 1 AC1 15 TYR B 15 PHE B 19 GLU B 28 SER B 91 SITE 2 AC1 15 GLN B 94 GLN B 143 TYR B 146 TYR B 147 SITE 3 AC1 15 VAL B 173 TRP B 179 TRP B 183 CYS B 196 SITE 4 AC1 15 PHE B 243 GLU B 246 HOH B 535 SITE 1 AC2 14 TYR A 15 PHE A 19 GLU A 28 GLN A 94 SITE 2 AC2 14 GLN A 143 TYR A 146 TYR A 147 VAL A 173 SITE 3 AC2 14 TRP A 179 TRP A 183 CYS A 196 PHE A 243 SITE 4 AC2 14 GLU A 246 HOH A 520 SITE 1 AC3 12 ARG B 6 SER B 7 TRP B 183 GLY B 187 SITE 2 AC3 12 PHE B 190 PRO B 191 ASP B 193 TYR B 198 SITE 3 AC3 12 THR B 245 THR B 247 HOH B 483 HOH B 499 SITE 1 AC4 10 ASP A 180 TRP A 183 LYS A 184 GLY A 187 SITE 2 AC4 10 PHE A 190 PRO A 191 TYR A 198 THR A 245 SITE 3 AC4 10 GLU A 246 THR A 247 CRYST1 130.890 130.890 63.320 90.00 90.00 120.00 P 6 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007640 0.004411 0.000000 0.00000 SCALE2 0.000000 0.008822 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015793 0.00000 MASTER 396 0 7 30 20 0 14 6 0 0 0 46 END